サマリー

気管支拡張症治療薬の世界市場 2023-2027
気管支拡張症治療薬市場は2022-2027年に3億2601万米ドルで成長し、予測期間中のCAGRは9.98%で加速すると予測されます。当レポートでは、気管支拡張症治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、関連リスク因子の症例増加、低コストの適応外ジェネリック医薬品の入手可能性、老年人口の急増によって牽引されています。
Technavio社の気管支拡張症治療薬市場は以下のように分類されます：
製品別
- 抗生物質
- 去痰薬
- その他
流通チャネル別
- オフライン
- オンライン
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、気管支拡張症に対する意識の高まりが、今後数年間の気管支拡張症治療薬市場の成長を促進する主な要因の1つであるとしている。また、呼吸器疾患の診断の進歩や標的治療に対する需要の高まりは、市場の大きな需要につながるでしょう。
本レポートでは、気管支拡張症治療薬市場について、以下の分野をカバーしています：
- 気管支拡張症治療薬市場の規模
- 気管支拡張症治療薬市場予測
- 気管支拡張症治療薬市場産業分析
本レポートでは、気管支拡張症治療薬市場の主要ベンダーであるAbbVie Inc.、Akorn Operating Co LLC、Amneal Pharmaceuticals Inc.、Aurobindo Pharma Ltd.、Bayer AG、Boehringing Co、Bayer AG、Boehringer Ingelheim International GmbH、Dr Reddys Laboratories Ltd.、Endo International Plc、GlaxoSmithKline Plc、Hikma Pharmaceuticals Plc、Lupin Ltd.、Neopharma Corp.、Pfizer Inc.、Reckitt Benckiser Group Plc、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Virtus Pharmaceuticals LLC、Wockhardt Ltd.、Zydus Lifesciences Ltd.などです。また、気管支拡張症治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/bronchiectasis-drugs-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global bronchiectasis drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global bronchiectasis drugs market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Antibiotics - Market size and forecast 2022-2027
o Exhibit 34: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
o 6.4 Expectorants - Market size and forecast 2022-2027
o Exhibit 38: Chart on Expectorants - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Expectorants - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Expectorants - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Expectorants - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Product
o Exhibit 46: Market opportunity by Product ($ million)
o Exhibit 47: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 50: Chart on Comparison by Distribution Channel
o Exhibit 51: Data Table on Comparison by Distribution Channel
o 7.3 Offline - Market size and forecast 2022-2027
o Exhibit 52: Chart on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 7.4 Online - Market size and forecast 2022-2027
o Exhibit 56: Chart on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Online - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ million)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. - Overview
o Exhibit 112: AbbVie Inc. - Product / Service
o Exhibit 113: AbbVie Inc. - Key news
o Exhibit 114: AbbVie Inc. - Key offerings
o 12.4 Akorn Operating Co LLC
o Exhibit 115: Akorn Operating Co LLC - Overview
o Exhibit 116: Akorn Operating Co LLC - Product / Service
o Exhibit 117: Akorn Operating Co LLC - Key offerings
o 12.5 Amneal Pharmaceuticals Inc.
o Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
o 12.6 Aurobindo Pharma Ltd.
o Exhibit 123: Aurobindo Pharma Ltd. - Overview
o Exhibit 124: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 125: Aurobindo Pharma Ltd. - Key offerings
o 12.7 Bayer AG
o Exhibit 126: Bayer AG - Overview
o Exhibit 127: Bayer AG - Business segments
o Exhibit 128: Bayer AG - Key news
o Exhibit 129: Bayer AG - Key offerings
o Exhibit 130: Bayer AG - Segment focus
o 12.8 Boehringer Ingelheim International GmbH
o Exhibit 131: Boehringer Ingelheim International GmbH - Overview
o Exhibit 132: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 133: Boehringer Ingelheim International GmbH - Key news
o Exhibit 134: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 135: Boehringer Ingelheim International GmbH - Segment focus
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 136: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 137: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 138: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 139: Dr Reddys Laboratories Ltd. - Segment focus
o 12.10 Endo International Plc
o Exhibit 140: Endo International Plc - Overview
o Exhibit 141: Endo International Plc - Business segments
o Exhibit 142: Endo International Plc - Key news
o Exhibit 143: Endo International Plc - Key offerings
o Exhibit 144: Endo International Plc - Segment focus
o 12.11 GlaxoSmithKline Plc
o Exhibit 145: GlaxoSmithKline Plc - Overview
o Exhibit 146: GlaxoSmithKline Plc - Business segments
o Exhibit 147: GlaxoSmithKline Plc - Key news
o Exhibit 148: GlaxoSmithKline Plc - Key offerings
o Exhibit 149: GlaxoSmithKline Plc - Segment focus
o 12.12 Hikma Pharmaceuticals Plc
o Exhibit 150: Hikma Pharmaceuticals Plc - Overview
o Exhibit 151: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 152: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 153: Hikma Pharmaceuticals Plc - Segment focus
o 12.13 Lupin Ltd.
o Exhibit 154: Lupin Ltd. - Overview
o Exhibit 155: Lupin Ltd. - Product / Service
o Exhibit 156: Lupin Ltd. - Key news
o Exhibit 157: Lupin Ltd. - Key offerings
o 12.14 Neopharma Corp.
o Exhibit 158: Neopharma Corp. - Overview
o Exhibit 159: Neopharma Corp. - Product / Service
o Exhibit 160: Neopharma Corp. - Key news
o Exhibit 161: Neopharma Corp. - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 162: Pfizer Inc. - Overview
o Exhibit 163: Pfizer Inc. - Product / Service
o Exhibit 164: Pfizer Inc. - Key news
o Exhibit 165: Pfizer Inc. - Key offerings
o 12.16 Reckitt Benckiser Group Plc
o Exhibit 166: Reckitt Benckiser Group Plc - Overview
o Exhibit 167: Reckitt Benckiser Group Plc - Business segments
o Exhibit 168: Reckitt Benckiser Group Plc - Key offerings
o Exhibit 169: Reckitt Benckiser Group Plc - Segment focus
o 12.17 Viatris Inc.
o Exhibit 170: Viatris Inc. - Overview
o Exhibit 171: Viatris Inc. - Business segments
o Exhibit 172: Viatris Inc. - Key news
o Exhibit 173: Viatris Inc. - Key offerings
o Exhibit 174: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global bronchiectasis drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Product ($ million)
Exhibits47: Data Table on Market opportunity by Product ($ million)
Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Akorn Operating Co LLC - Overview
Exhibits116: Akorn Operating Co LLC - Product / Service
Exhibits117: Akorn Operating Co LLC - Key offerings
Exhibits118: Amneal Pharmaceuticals Inc. - Overview
Exhibits119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits120: Amneal Pharmaceuticals Inc. - Key news
Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits123: Aurobindo Pharma Ltd. - Overview
Exhibits124: Aurobindo Pharma Ltd. - Product / Service
Exhibits125: Aurobindo Pharma Ltd. - Key offerings
Exhibits126: Bayer AG - Overview
Exhibits127: Bayer AG - Business segments
Exhibits128: Bayer AG - Key news
Exhibits129: Bayer AG - Key offerings
Exhibits130: Bayer AG - Segment focus
Exhibits131: Boehringer Ingelheim International GmbH - Overview
Exhibits132: Boehringer Ingelheim International GmbH - Business segments
Exhibits133: Boehringer Ingelheim International GmbH - Key news
Exhibits134: Boehringer Ingelheim International GmbH - Key offerings
Exhibits135: Boehringer Ingelheim International GmbH - Segment focus
Exhibits136: Dr Reddys Laboratories Ltd. - Overview
Exhibits137: Dr Reddys Laboratories Ltd. - Business segments
Exhibits138: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits139: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits140: Endo International Plc - Overview
Exhibits141: Endo International Plc - Business segments
Exhibits142: Endo International Plc - Key news
Exhibits143: Endo International Plc - Key offerings
Exhibits144: Endo International Plc - Segment focus
Exhibits145: GlaxoSmithKline Plc - Overview
Exhibits146: GlaxoSmithKline Plc - Business segments
Exhibits147: GlaxoSmithKline Plc - Key news
Exhibits148: GlaxoSmithKline Plc - Key offerings
Exhibits149: GlaxoSmithKline Plc - Segment focus
Exhibits150: Hikma Pharmaceuticals Plc - Overview
Exhibits151: Hikma Pharmaceuticals Plc - Business segments
Exhibits152: Hikma Pharmaceuticals Plc - Key offerings
Exhibits153: Hikma Pharmaceuticals Plc - Segment focus
Exhibits154: Lupin Ltd. - Overview
Exhibits155: Lupin Ltd. - Product / Service
Exhibits156: Lupin Ltd. - Key news
Exhibits157: Lupin Ltd. - Key offerings
Exhibits158: Neopharma Corp. - Overview
Exhibits159: Neopharma Corp. - Product / Service
Exhibits160: Neopharma Corp. - Key news
Exhibits161: Neopharma Corp. - Key offerings
Exhibits162: Pfizer Inc. - Overview
Exhibits163: Pfizer Inc. - Product / Service
Exhibits164: Pfizer Inc. - Key news
Exhibits165: Pfizer Inc. - Key offerings
Exhibits166: Reckitt Benckiser Group Plc - Overview
Exhibits167: Reckitt Benckiser Group Plc - Business segments
Exhibits168: Reckitt Benckiser Group Plc - Key offerings
Exhibits169: Reckitt Benckiser Group Plc - Segment focus
Exhibits170: Viatris Inc. - Overview
Exhibits171: Viatris Inc. - Business segments
Exhibits172: Viatris Inc. - Key news
Exhibits173: Viatris Inc. - Key offerings
Exhibits174: Viatris Inc. - Segment focus
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations